// App-Quantinova.ai

AB0307 (2021) : IS THERE ANY INFLUENCE OF THE ANTIRHEUMATIC THERAPY ON ECHOCARDIOGRAPHIC FINDINGS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS?

Researchers

Presenter

  • T. Panafidina

Principal Investigators

  • T. Popkova

  • L. Kondrateva

  • A. Volkov

  • E. Nasonov

  • A. Lila

Medical Centers

  • VA Nasonova Research Institute of Rheumatology, of Systemic Rheumatic Diseases, Moscow, Russian Federation

  • V. A. Nasonova Research Institute of Rheumatology, Department of osteoporosis, Moscow, Russian Federation

  • VA Nasonova Research Institute of Rheumatology, of Systemic Rheumatic Diseases, Moscow, Russian Federation

Locations

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Hydroxychloroquine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Oraprine

  • Methotrexate

  • Prednisone

  • Belimumab

  • Rituximab

Outcome

  • N/A

Study Design

  • Prospective

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved